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36 post-surgery using the Mann-Whitney test. Pearson correla-
tion coefﬁcients were calculated between utility scores and the
KOOS overall, KOOS quality of life and VAS scores at each
time-point. RESULTS: Signiﬁcantly higher utility scores were
observed in KOOS responders compared to non-responders at
Months 30 (0.817 vs. 0.691, n = 25/14, p = 0.004) and 36 (0.775
vs. 0.618, n = 19/6, p = 0.006) and in VAS responders compared
to non-responders at Months 24 (0.827 vs. 0.701, n = 17/9,
p = 0.038) and 36 (0.764 vs. 0.600, n = 21/4, p = 0.015). A
similar trend of borderline signiﬁcance was measured at Months
24 (using KOOS, 0.818 vs. 0.728, n = 16/10, p = 0.136) and 30
(using VAS, 0.800 vs. 704, n = 21/4, p = 0.053). Utility scores
correlated best with the KOOS overall (Pearson coefﬁcients
ranged from 0.579 to 0.721, p-values < 0.01) and VAS scores
(-0.514 to -0.671, p-values < 0.01). CONCLUSIONS: Gaps in
utility scores between responders (= successful surgery) and non-
responders ranged from 0.091 to 0.164. This ﬁnding validates
the assumption made in a previous Health Technology Assess-
ment on Autologous Chondrocytes Implantation. Consistent
gaps and signiﬁcant correlations with validated tools provide
valuable information for future economic modeling of CCI.
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OBJECTIVES: QOL (quality of life) is critical in the manage-
ment of patients with rheumatoid arthritis (RA). To evaluate the
QOL of RA patients with different background, we evaluated the
QOL by using Japanese version of EuroQol (EQ-5D) in a large
observational cohort study of Japanese RA patients, IORRA.
METHODS: We have established a large observational cohort of
RA patients IORRA (Institute Of Rheumatology Rheumatoid
Arthritis) in the Institute of Rheumatology Tokyo Women’s
Medical University since 2000. Essentially all RA patients who
consulted there were registered, and clinical parameters including
the disease activity, use of drugs and the occurrence of adverse
events in daily clinical settings were assessed biannually based on
patient’s report, physician’s examination and laboratory data. In
this cohort, we evaluated the QOL of RA patients by EQ-5D,
disease activity by DAS28, and disability by JHAQ, and then we
analyzed the related factors for EQ-5D by Spearman’s correla-
tion. RESULTS: In September 2007, a total 5023 RA patients
(female 84.2%, average 58.02 years-old, average disease dura-
tion 11.26 years, rheumatoid factor positive 74.8%, patients
taking steroid, methotrexate and biologics were 51.0%, 63.6%,
and 4.3%, respectively) fulﬁlled the questionnaire of EQ-5D.
Mean  SD of EQ-5D, DAS28 and JHAQ was 0.757  0.178,
3.28  1.147 and 0.737  0.769, respectively, EQ-5D was
worse in female (0.75  0.177) than in male (0.798  0.177)
patients, and worse in rheumatoid factor positive (0.75  0.178)
than negative (0.782  0.175) patients. EQ-5D became worse by
older age and longer disease duration. No clear relationship was
identiﬁed between EQ-5D and medications including corticoster-
oid, methotrexate or biologics in this cross-sectional analysis.
CONCLUSIONS: EQ-5D based QOL was analyzed in a large
number of Japanese RA patients using IORRA cohort.
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OBJECTIVES: The absence of objective signs and lack of tests
make patient complaints fundamental to a presumptive diagnosis
of ﬁbromyalgia. To make diagnosis easier, H. Moldofsky has
developed a questionnaire of 6 items related to diffuse pain,
fatigue, psychological distress, unrestorative sleep and impaired
well-being. To validate the FMQ (Fibromyalgia Moldofsky Ques-
tionnaire) as a tool to aid diagnosis,METHODS:A representative
sample of 1500 subjects from the general UK population was
constituted using the quotamethod. The FMQquestionnaire, was
administered along with two validated questionnaires (LFESSQ
London Fibromyalgia Epidemiology Study Screening Question-
naire and CES-D Center for Epidemiologic Studies Depression
Scale) and a questionnaire assessing a decline in the restorative
effects of sleep (SQA Sleep Quality Assessment). The maximum
score of 18 reﬂected a strong presumption of ﬁbromyalgia
syndrome. Internal consistency, structural and clinical validity
were tested. The sensitivity and speciﬁcity were also assessed,
RESULTS: Internal consistency was satisfactory (aCronbach > 0.7).
The items composing each dimensionwere pertinent to the dimen-
sion that they represented (R > 0.4) and were not correlated with
any other dimension. Subjects responding positively on the
LFESSQ had an FMQ score that was signiﬁcantly higher than
subjects who responded negatively (8.6 [7.9–9.3] vs 4.1 [3.9–4.3],
p < 0.001). Similar differences were observed between those sub-
jects who had or did not have probable depressive symptoms (8.0
[7.4–8.6] vs 4.0 [3.8–4.2], p < 0.001) and between subjects expe-
riencing a decline in the restorative effect of sleep or not (7.3
[7.0–7.6] vs 3.5 [3.3–3.7], p < 0.001).The FMQ had a sensitivity
of 46 to 54%, depending on the speciﬁc dimension and question-
naire studied. Speciﬁcity was optimal (90 to 95%), CONCLU-
SIONS: The results observed during this psychometric validation
showed that the FMQ questionnaire responded to the objectives
that we had established and therefore allows referring physicians
to send subjects with presumed ﬁbromyalgia to specialist investi-
gation centres.
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OBJECTIVES: To determine the validity and responsiveness of
the novel disease-speciﬁc Work Productivity Survey (WPS-RA) in
patients with active rheumatoid arthritis (RA). The WPS-RA
captures the RA impact on work and home-related.productivity.
METHODS: A total of 220 RA subjects were randomized to
400 mg of subcutaneous certolizumab pegol or placebo every 4
weeks, for 24 weeks (wks). The WPS-RA was completed monthly
starting Baseline (BL) until withdrawal/completion. Validity was
evaluated at BL, using the known-groups approach. Mean
WPS-RA responses at BL were compared between subjects with
different levels of physical function or health-related quality-of-
life (HRQoL). Groups were deﬁned by the median-cut of sub-
jects’ scores to Health Assessment Questionnaire Disability Index
(HAQ-DI) and SF-36 (the physical and mental component sum-
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